Seven of eight analysts rate it a buy, targeting 15% upside
In the quiet calculus of markets, Keysight Technologies stands at a crossroads familiar to any maturing enterprise: having demonstrated operational strength through a quarter of solid earnings, it now invites the considered judgment of analysts, institutions, and insiders alike. Eight Wall Street voices have coalesced around a price target of $187.38 — roughly 15 percent above where shares currently rest — reflecting a broader conviction that the company's role supplying test equipment to aerospace, defense, and semiconductor industries positions it well for the chapters ahead. The story is not one of sudden revelation, but of gradual confirmation: fundamentals strengthening, institutions accumulating, and the market slowly closing the distance between present reality and future possibility.
- Keysight's Q3 earnings cleared expectations on both profit and revenue, with 11.1% year-over-year growth signaling that demand for electronic test equipment remains resilient across defense, automotive, and semiconductor sectors.
- Eight analysts have converged on a $187.38 consensus price target, with seven of eight rating the stock a buy — a rare degree of alignment that amplifies pressure on the current $163.42 share price to move.
- JPMorgan raised its target aggressively to $200, while Barclays trimmed slightly to $195 but held its overweight stance, illustrating the tension between bullish conviction and cautious recalibration at the top of the range.
- Insider selling by the CFO and a senior vice president drew attention, but institutional investors told a different story — some nearly doubling or tripling their positions, pushing institutional ownership to 84.58% of shares outstanding.
- With a debt-to-equity ratio of 0.45, a quick ratio of 2.94, and full-year EPS guidance of $7.09, the balance sheet projects the kind of stability that sustains analyst confidence even as the stock approaches its 12-month high of $186.20.
Keysight Technologies closed Friday at $163.42, with eight Wall Street analysts collectively pointing toward $187.38 as a fair destination over the next twelve months — a roughly 15 percent premium to current levels. Seven of those eight rate the stock a buy, producing a consensus of moderate conviction rather than euphoria.
The foundation for that optimism arrived in late August, when Keysight reported third-quarter results that beat expectations on both lines. Earnings per share came in at $1.72 against a $1.67 estimate, while revenue of $1.35 billion edged past the $1.32 billion analysts had anticipated. Year-over-year revenue growth of 11.1 percent is a meaningful pace for a $28 billion company that sells electronic test equipment to aerospace, defense, automotive, and semiconductor customers.
Among the analysts, JPMorgan moved most boldly, raising its target to $200 in July with an overweight rating. Morgan Stanley lifted its target to $180 in May, and Barclays, while trimming slightly from $200 to $195 in August, held its overweight stance. Bank of America raised its target to $179 but assigned a neutral rating — a note of caution within an otherwise constructive chorus.
The balance sheet reinforces the case. A quick ratio of 2.94 and a current ratio of 3.59 reflect strong liquidity, while a debt-to-equity ratio of 0.45 signals conservative leverage. Return on equity reached 19.53 percent last quarter. Management has guided full-year 2025 earnings per share to $7.09, with fourth-quarter guidance of $1.79 to $1.85.
Insider activity offered a mixed signal. CFO Neil Dougherty and Senior Vice President Ingrid Estrada each sold shares in June — modest reductions that read more as routine portfolio management than as warnings. Institutional investors, meanwhile, moved in the opposite direction. Several funds significantly expanded their positions in the first half of the year, and institutions now hold 84.58 percent of the company's shares — a concentration that speaks to Keysight's standing among large asset managers.
With the 50-day moving average nearly aligned with the current price and the stock trading well above its 12-month low of $121.43, Keysight appears to be in a period of consolidation before its next move. Whether that move closes the gap to the analyst consensus target may depend on whether the company's fourth quarter confirms what the third quarter suggested: that the momentum is real.
Keysight Technologies closed Friday trading at $163.42, a stock that has caught the attention of eight major Wall Street analysts who collectively believe it has room to run. Their consensus price target sits at $187.38 over the next twelve months—a gain of roughly 15 percent from where shares currently trade. Seven of those eight analysts rate the company a buy, with one holding steady. The overall assessment: a moderate buy.
The optimism isn't unfounded. In late August, Keysight reported third-quarter earnings that cleared the bar set by expectations. The company posted $1.72 in earnings per share, beating the consensus estimate of $1.67. Revenue came in at $1.35 billion, also ahead of the $1.32 billion analysts had penciled in. Year-over-year, the top line grew 11.1 percent, a solid clip for a company with a $28.13 billion market capitalization that designs and sells electronic test equipment to the aerospace, defense, automotive, semiconductor, and communications industries.
JPMorgan Chase moved most aggressively in July, raising its target from $177 to $200 and assigning an overweight rating. Morgan Stanley followed suit in May, lifting its target from $156 to $180. Barclays, meanwhile, trimmed its target slightly in August from $200 to $195 but maintained an overweight stance. Bank of America raised its target from $175 to $179, though it assigned a neutral rating rather than a buy. These moves reflect a broad conviction that Keysight's fundamentals are strengthening even as the stock has climbed from its 12-month low of $121.43 toward its recent high of $186.20.
The company's balance sheet underscores the stability analysts are betting on. Keysight carries a quick ratio of 2.94 and a current ratio of 3.59, both healthy measures of short-term liquidity. Its debt-to-equity ratio stands at 0.45, indicating conservative leverage. Return on equity hit 19.53 percent last quarter, and net margins held at 10.36 percent. For the full year 2025, management has guided earnings per share to $7.09, with fourth-quarter guidance set at $1.79 to $1.85 per share.
Insiders have been selling modest amounts of stock. In June, Chief Financial Officer Neil Dougherty sold 12,215 shares at an average price of $164.60, reducing his stake by about 9.6 percent but still leaving him with 115,228 shares worth roughly $19 million. Senior Vice President Ingrid Estrada sold 10,000 shares the same month at $158.97 each, a transaction that represented an 8.4 percent reduction in her position. These sales, while notable, are routine portfolio management rather than signs of distress. Insiders as a group own just 0.61 percent of the company.
Institutional investors, by contrast, have been accumulating. Central Pacific Bank Trust Division nearly doubled its position in the first quarter. True Wealth Design LLC increased its holdings by 358 percent in the second quarter. NewSquare Capital and Atlantic Union Bankshares both initiated or expanded positions during the first half of the year. Institutional investors now own 84.58 percent of Keysight's shares, a concentration that reflects the stock's appeal to large asset managers.
The 50-day moving average sits at $163.76, nearly aligned with the current price, while the 200-day average stands at $157.55. The stock's beta of 1.16 suggests it moves somewhat more than the broader market. Analysts surveyed by the company expect it to earn $6.32 per share in the current year, a figure that would support the current valuation and the upside the consensus target implies. For investors watching the test-and-measurement space, Keysight's combination of earnings momentum, analyst support, and institutional buying suggests the story may still have chapters ahead.
Citas Notables
The company reported $1.72 in earnings per share, beating the consensus estimate of $1.67, with revenue of $1.35 billion exceeding the $1.32 billion analysts had expected— Keysight Technologies Q3 2025 earnings report
La Conversación del Hearth Otra perspectiva de la historia
Why are eight different analysts all converging on roughly the same price target? That seems unusual.
It's not that they're all thinking identical thoughts—JPMorgan sees $200, Barclays sees $195, Morgan Stanley sees $180. But they're all pointing in the same direction because the company just proved it can grow revenue double digits while beating earnings estimates. That's the kind of thing that makes skeptics believers.
The CFO and a senior VP both sold stock in June. Doesn't that worry you?
Not really. They each trimmed maybe 8 to 10 percent of their holdings. That's normal portfolio rebalancing, not a fire sale. They still own millions of dollars worth. If they were panicking, they'd dump everything.
What's the actual business here? Why does anyone care about Keysight?
They make the equipment that engineers use to design and test everything from semiconductors to 5G networks to defense systems. It's unglamorous but essential. When the world builds new technology, Keysight's tools are in the room.
The stock's already climbed from $121 to $163 in a year. Is there really 15 percent more upside left?
That depends on whether you believe the earnings growth continues. The company guided full-year EPS to $7.09 and next quarter to $1.79 to $1.85. If they hit those numbers, the stock probably deserves to trade higher. If they miss, the consensus target becomes a ceiling instead of a floor.
Who's actually buying? Is it retail or institutions?
Institutions own 84 percent of the stock. These are the big asset managers and pension funds. Retail investors are along for the ride, but the real money is institutional. That's both stabilizing and limiting—it means the stock won't crash on a bad day, but it also means there's less room for a surprise rally.